Abstract Information on the immune response during the mpox virus (MPXV) infection is still
scarce or limited to past studies when cross‐reactive immunity from smallpox vaccination …

The 2022 global outbreak of clade IIb mpox was the first major outbreak of mpox outside of
African nations. To control the outbreak, vaccination campaigns were begun using the third …

When the Mpox virus (MPXV) began spreading globally in 2022, it became critical to
evaluate whether residual immunity from smallpox vaccination provided cross-protection. To …

Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022.
Following historic success of smallpox vaccination with vaccinia virus (VACV)-based …

The ongoing pandemic caused by mpox virus (MPXV) has become an international public
health emergency that poses a significant threat to global health. The vaccinia virus Tiantan …

An ongoing outbreak of monkeypox virus (MPXV) was first reported in the United Kingdom
on 6 May 2022. As of 17 November, there had been a total of 80 221 confirmed MPXV cases …

Since May 2022, human mpox cases have increased unexpectedly in non-endemic
countries. The first imported case of human mpox in Hong Kong was reported in September …

The Mpox virus (MPXV) is endemic in certain countries in Central and West Africa, where
several mammalian species, especially rodents, are natural reservoirs. However, the MPXV …

Background After months of few mpox cases, an increase in cases was reported in Chicago
during May 2023, predominantly among fully vaccinated (FV) patients. We investigated the …

Background Since the emergence of the global mpox outbreak in May, 2022, more than 90
000 cases have been diagnosed across 110 countries, disproportionately affecting people …